DKSH Continues Strengthening its Healthcare Own Brands Business With the Acquisition of two Brands From Eisai
Retrieved on:
Monday, November 7, 2022
Technology, United Nations Global Compact, Growth, Strategic business unit, DKSH, SIX Swiss Exchange, Vertigo, CHF, OTC, E-commerce, Dizziness, Sustainability, Marketing, Acquisition, Final good, Small Business Saturday, Media relations, Retail, Pharmaceutical industry, Fine chemical, Eisai, Eperisone
With the acquisition, DKSH continues its strategy to expand its Healthcare Own Brands portfolio and to grow in Asia Pacific.
Key Points:
- With the acquisition, DKSH continues its strategy to expand its Healthcare Own Brands portfolio and to grow in Asia Pacific.
- DKSH already markets these products for Eisai in most of the nine Asian markets and with the acquisition now becomes full brand owner.
- Bijay Singh, Head Business Unit Healthcare at DKSH, commented: This acquisition is another indicator of our commitment to growing our Own Brands portfolio.
- The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices.